Skip to Content

Xultophy

In the US, Xultophy (insulin degludec/liraglutide systemic) is a member of the drug class antidiabetic combinations and is used to treat Diabetes, Type 2.

US matches:

UK matches:

Ingredient matches for Xultophy

Insulin Degludec

Insulin Degludec is reported as an ingredient of Xultophy in the following countries:

  • Germany
  • Poland
  • Switzerland
  • United Kingdom

Liraglutide

Liraglutide is reported as an ingredient of Xultophy in the following countries:

  • Germany
  • Poland
  • Switzerland
  • United Kingdom

← International Drug Name Search

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide